KDR and coronary artery disorder: It is also upregulated in endothelial progenitor cells of coronary artery disease (CAD) patients, where it jointly suppresses VEGFR2 expression, affecting blood flow recovery in ischemic tissues and providing a potential therapeutic target for CAD [87].